A MOLECULAR APPROACH TO GONADOTROPIN RECEPTOR REGULATION
促性腺激素受体调节的分子方法
基本信息
- 批准号:3320172
- 负责人:
- 金额:$ 9.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-08-01 至 1989-11-30
- 项目状态:已结题
- 来源:
- 关键词:active immunization antibody formation autoradiography chorionic gonadotropin chromatography density gradient ultracentrifugation electrophoresis histochemistry /cytochemistry hormone biosynthesis hormone receptor hormone regulation /control mechanism immunochemistry laboratory mouse laboratory rabbit laboratory rat luteinizing hormone monoclonal antibody ovary passive immunization radioassay swine
项目摘要
We have successfully developed procedures to solubilize LH/hCG receptors
(LHR) from porcine and rat ovaries in high yield. Porcine and rat LHR have
been purified to apparent homogeneity by a two-step hCG-Sepharose affinity
chromatographic procedure. The predominant subunit of LHR so purified has
a molecular weight of 70,000 - 80,000 Daltons under denaturing reducing
conditions. During the proposed grant period, the physico-chemical and
biological properties of purified rat and porcine LHR will be compared.
Antibodies to porcine LHR will be developed in rabbits, and rat LHR will be
injected into mice with the goal of producing a monoclonal antibody to rat
LHR. Antibodies will be characterized by immunochemical techniques and
their biological properties will be tested using isolated receptors,
membranes, cultured cells and the whole animal. The molecular basis of
receptor regulation by hormones will be analyzed through direct
measurements of rates of synthesis and degradation of LHR by specific
immunoprecipitation methodology.
Receptor antibodies will provide a superb analytical tool for investigation
of the molecular biology of LHR synthesis, processing and turnover. LHR
antibodies will not only be critical tools for investigation of ovarian
physiology at the molecular level, but also may have significant practical
application in immunocontraception and in understanding infertility of
ovarian origin and in the development of monoclonal LHR antibody-drug
conjugates which may be useful in therapy of ovarian cancer.
我们已经成功地开发了溶解LH/hCG受体的程序
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAY wimalasena WIMALASENA其他文献
JAY wimalasena WIMALASENA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAY wimalasena WIMALASENA', 18)}}的其他基金
REGULATION OF BREAST CANCER CELL CYCLE BY ESTRADIOL
雌二醇对乳腺癌细胞周期的调节
- 批准号:
2429869 - 财政年份:1996
- 资助金额:
$ 9.9万 - 项目类别:
REGULATION OF BREAST CANCER CELL CYCLE BY ESTRADIOL
雌二醇对乳腺癌细胞周期的调节
- 批准号:
2112531 - 财政年份:1996
- 资助金额:
$ 9.9万 - 项目类别:
REGULATION OF BREAST CANCER CELL CYCLE BY ESTRADIOL
雌二醇对乳腺癌细胞周期的调节
- 批准号:
2712747 - 财政年份:1996
- 资助金额:
$ 9.9万 - 项目类别:
EFFECTS OF ALCOHOL ON HUMAN OVARIAN CELL FUNCTION
酒精对人类卵巢细胞功能的影响
- 批准号:
3112386 - 财政年份:1992
- 资助金额:
$ 9.9万 - 项目类别:
EFFECTS OF ALCOHOL ON HUMAN OVARIAN CELL FUNCTION
酒精对人类卵巢细胞功能的影响
- 批准号:
2044423 - 财政年份:1992
- 资助金额:
$ 9.9万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 9.9万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 9.9万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 9.9万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 9.9万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 9.9万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 9.9万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 9.9万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 9.9万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 9.9万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 9.9万 - 项目类别:














{{item.name}}会员




